Ptc Therapeutics Stock Technical Analysis
| PTCT Stock | USD 24.69 0.47 1.87% |
As of the 19th of April, PTC Therapeutics owns the market risk adjusted performance of (0.07), and Coefficient Of Variation of (1,914). In relation to fundamental indicators, the technical analysis model allows you to check practical technical drivers of PTC Therapeutics, as well as the relationship between them. Strictly speaking, you can use this information to find out if the company will indeed mirror its model of historical prices and volume patterns, or the prices will eventually revert. We were able to break down thirteen technical drivers for PTC Therapeutics, which can be compared to its peers in the sector. Please check PTC Therapeutics mean deviation, treynor ratio, as well as the relationship between the Treynor Ratio and kurtosis to decide if PTC Therapeutics is priced fairly, providing market reflects its prevailing price of 24.69 per share. Given that PTC Therapeutics has information ratio of (0.07), we recommend you to check out PTC Therapeutics's latest market performance to make sure the company can sustain itself at some point in the future.
PTC Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as PTC, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to PTCPTC |
PTC Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 35.42 | Buy | 14 | Odds |
Most PTC analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand PTC stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of PTC Therapeutics, talking to its executives and customers, or listening to PTC conference calls.
PTC Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
PTC Therapeutics Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of PTC Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
PTC Therapeutics Trend Analysis
Use this graph to draw trend lines for PTC Therapeutics. You can use it to identify possible trend reversals for PTC Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual PTC Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.PTC Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for PTC Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.03 , which means PTC Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 26.75, which is the sum of squared deviations for the predicted PTC Therapeutics price change compared to its average price change.About PTC Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of PTC Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of PTC Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on PTC Therapeutics price pattern first instead of the macroeconomic environment surrounding PTC Therapeutics. By analyzing PTC Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of PTC Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to PTC Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 (projected) | Graham Number | 1.85 | 29.13 | 45.39 | Receivables Turnover | 4.88 | 4.49 | 5.82 |
PTC Therapeutics April 19, 2024 Technical Indicators
Most technical analysis of PTC help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for PTC from various momentum indicators to cycle indicators. When you analyze PTC charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.07) | |||
| Mean Deviation | 2.42 | |||
| Coefficient Of Variation | (1,914) | |||
| Standard Deviation | 3.28 | |||
| Variance | 10.77 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (0.49) | |||
| Treynor Ratio | (0.08) | |||
| Maximum Drawdown | 19.51 | |||
| Value At Risk | (5.68) | |||
| Potential Upside | 4.89 | |||
| Skewness | 1.03 | |||
| Kurtosis | 3.41 |
PTC Therapeutics April 19, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as PTC stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 26,276 | ||
| Daily Balance Of Power | (0.58) | ||
| Rate Of Daily Change | 0.98 | ||
| Day Median Price | 24.88 | ||
| Day Typical Price | 24.81 | ||
| Price Action Indicator | (0.42) |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PTC Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy PTC Stock please use our How to Invest in PTC Therapeutics guide.Note that the PTC Therapeutics information on this page should be used as a complementary analysis to other PTC Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for PTC Stock analysis
When running PTC Therapeutics' price analysis, check to measure PTC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PTC Therapeutics is operating at the current time. Most of PTC Therapeutics' value examination focuses on studying past and present price action to predict the probability of PTC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PTC Therapeutics' price. Additionally, you may evaluate how the addition of PTC Therapeutics to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is PTC Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PTC Therapeutics. If investors know PTC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PTC Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.37) | Revenue Per Share 12.531 | Quarterly Revenue Growth 0.834 | Return On Assets (0.12) | Return On Equity (77.40) |
The market value of PTC Therapeutics is measured differently than its book value, which is the value of PTC that is recorded on the company's balance sheet. Investors also form their own opinion of PTC Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is PTC Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PTC Therapeutics' market value can be influenced by many factors that don't directly affect PTC Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PTC Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if PTC Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PTC Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.